Varian Medical Systems stock got clobbered July 14, dropping nearly $8 per share to about $67, after the company reported that orders for oncology equipment from North American customers were flat in the fiscal third quarter. The announcement was made
Varian Medical Systems stock got clobbered July 14, dropping nearly $8 per share to about $67, after the company reported that orders for oncology equipment from North American customers were flat in the fiscal third quarter. The announcement was made ahead of the scheduled July 29 earnings release in response to high-volume, volatile trading. The knee-jerk reaction to the announcement reflects the importance of the U.S. market, as it was swaddled in otherwise good news-an expected 30% jump in overall earnings on a 14% rise in sales per share for the third quarter compared with the previous year's period.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.